Peptide C Terminal Amidation Identity Confirmation

What does peptide C terminal amidation identity confirmation establish?

Peptide C terminal amidation identity confirmation establishes that the species under test carries a primary amide at the designed carboxyl terminus, and that the assignment is not borrowed from a co-eluting acid, a residual ester, or an amide at another site. The attribute is structural. A C-terminal carboxylate can be deprotonated and can form a salt with a counter-ion. A C-terminal primary amide is neutral at that position and presents hydrogen-bond donors on the nitrogen. Structural work treats the two forms as non-equivalent analytes because charge and hydrogen-bonding at the chain end differ. That is an identity fact, not a statement about activity in any biological system.

The same attribute has a purity context. Orange flavedo peptide amidase catalyses C-terminal peptide amidation, and substrate specificity in organic media is sequence-dependent, so incomplete conversion is a chemical expectation rather than an anomaly (Čeřovský and colleagues, 1998; Čeřovský and colleagues, 2001). The unconverted acid or ester is a related substance of nearly the same mass and often similar reversed-phase behaviour. Recombinant processing raises the same point: C-terminal amidation of a recombinant peptide is an outcome that has to be shown, not inferred from the construct alone (Zhang and colleagues, 2004).

A closed identity statement therefore has three parts. The intact mass must match the amidated elemental composition within the laboratory's stated tolerance, after adducts are assigned. The site of the amide must be localised, because an α-amide is not unique to the C-terminus. The acid form, and any ester used as substrate, must appear as specified related substances or as explicitly undetected within the method's reporting threshold. One major chromatographic peak, without an orthogonal mass result and without a site assignment, does not close the question. A nominal-mass reading that is equally compatible with the acid form plus a one-dalton calibration offset does not close it either.

How should exact mass be read against the acid and amide formulae?

The monoisotopic difference between a C-terminal carboxylic acid and the corresponding primary amide is 0.984 Da, the difference between a terminal hydroxyl and a terminal amino group. On a nominal-mass scale the two compositions sit one integer apart. An uncorrected calibration error of similar size can exchange the assignment. High-resolution measurement separates the formulae only when accuracy is tighter than that gap and the ion type is known. Protonated molecules, sodium adducts and potassium adducts each move the observed mass-to-charge ratio by a defined increment. Calling an amide an acid-plus-sodium, or calling an acid an amide because the wrong isotope was labelled, is an identity error.

The isotope cluster is part of the result. As chain length increases, the monoisotopic peak is no longer the tallest line in the envelope. If processing labels a 13C peak, or reports an average mass beside a monoisotopic theory, the discrepancy can be about one dalton, in the same direction as the amide–acid gap. A defensible record states whether the value is monoisotopic or average, the charge state, the adduct, and the mass error against both formulae. Printing only the closer match hides how decisive the measurement was.

Deamidation of asparagine or glutamine adds 0.984 Da. An amidated peptide that has undergone one such deamidation can share a composition with the unmodified acid. Intact mass cannot resolve that pair. Fragment ions, or another localisation result, have to place the extra oxygen before either hypothesis is retired. Until then the record should say that the intact mass is consistent with more than one terminus-and-deamidation hypothesis.

Counter-ions do not change covalent mass, but acetate or trifluoroacetate adducts can persist in the spectrum. Naming the counter-ion stops a later reader from treating an adduct as evidence for or against amidation. Where both formulae remain open after exact mass, a survival-yield comparison has been used to reveal C-terminal amidation as an orthogonal gas-phase observation (Logerot and colleagues, 2022).

Why is an amide mass not proof of a C-terminal site?

Sajapin and colleagues reported that methionine-associated peptide α-amidation is directed both to the N- and the C-terminal amino acids (Sajapin and colleagues, 2022). An amide mass is therefore not proof of a designed C-terminus. A peptide with one α-amide has the same elemental composition whether that amide is at the N-terminal residue or the C-terminal residue. Intact mass, however accurate, cannot separate those isomers. Only fragment evidence, or another site-specific result, can.

N-terminal and C-terminal fragment series do different jobs. Ions of the b and a series report the N-terminal portion of the chain. Ions of the y series report the C-terminal portion. If the amide is C-terminal, the y ions are shifted by about −0.984 Da relative to acid-form y ions, while b ions that do not contain the C-terminus match the unmodified N-terminal sequence. If the amide is associated with the N-terminal residue, the shift appears in the N-terminal fragments and the y ions match the acid-form C-terminus. A record that quotes only an intact mass, or only a single internal ion, does not make that distinction.

Methionine is the structural clue named in that report. A sequence that contains methionine warrants an explicit check for unexpected α-amidation when the specification is a free acid, and an explicit site check when the specification is a C-terminal amide. Presence of methionine does not prove that the side reaction occurred. It marks a risk the method must be able to see. Chromatographic peak purity does not locate the amide. Sequence isomers may co-elute, and a diode-array peak-purity index does not read residue position.

Documentation should keep three statements apart: amide present; amide located at the C-terminus; no additional α-amide at the N-terminus. Each needs its own evidence line and a spectrum identifier. Where fragment coverage misses either terminus, the identity conclusion stays open.

How does survival yield reveal C-terminal amidation without a purity claim?

Survival yield is the fraction of a selected precursor that remains intact after a defined collisional activation, taken against the sum of surviving precursor and observed fragments. Plotted against activation energy, the fraction forms a curve. The energy at which half the precursor survives is a common comparative index. Logerot and colleagues showed that this survival-yield technique can reveal C-terminal peptide amidation (Logerot and colleagues, 2022). The acid and the amide are then distinguished not only by a 0.984 Da gap, which exact mass can leave ambiguous, but also by gas-phase fragmentation behaviour under the same activation regime.

The curve must be read for what it compares. Survival yield is not a purity percentage and it is not a chromatographic peak area. It is a gas-phase stability readout for one isolated precursor. A difference relative to an amide reference and an acid reference of the same sequence is an identity observation. A difference relative to an unrelated peptide is not, because sequence, charge state and the number of internal degrees of freedom all move the curve. The record should name the reference pair, the charge state, the activation type and the energy scale. Without those fields, two lots cannot be compared later on a stated basis.

The technique does not replace site localisation. A survival-yield difference can support the conclusion that the precursor behaves as the amidated form rather than the acid form. It does not map which residue carries the amide if more than one site is plausible, including the N- versus C-terminal ambiguity already noted for methionine-associated α-amidation. Placed after an exact-mass screen and beside fragment assignment, it is an orthogonal line. Used alone, it classifies gas-phase behaviour only.

Two limits belong on the method note. In-source fragmentation, or a contaminant inside the isolation window, can lower apparent survival yield and imitate a less stable terminus, so the isolation window and the preceding separation are part of the result's meaning. The numerical index should be stored with the curve or the underlying survival values, not only as an unexplained pass or fail.

Which related substances and record fields close the amide assignment?

Enzymatic C-terminal amidation moves the identity question from coupling chemistry to measured conversion. Orange flavedo peptide amidase catalyses the transformation, and studies in organic media show that substrate specificity is part of the result, not a footnote (Čeřovský and colleagues, 1998; Čeřovský and colleagues, 2001). A conversion reported for one sequence is not evidence for another. Citing a generic amidase method, without a residual-substrate result for the lot, overstates what that literature supports. Computational redesign of an amidation enzyme has been aimed at tolerance to denaturants (Zhu and colleagues, 2024). Denaturants and organic components are process-related materials. They are not covalent features of the peptide, but they can shift retention or suppress ionisation, and they should stay outside the peptide purity arithmetic.

The related substance that most directly threatens the identity call is residual C-terminal acid or ester. It differs from the amide by about 0.984 Da, or by the ester mass if an ester was the substrate. Ultraviolet area percent describes chromophore distribution under the stated wavelength. It does not state whether the main peak is the amide. Identity and related-substance lines have to agree. Recombinant amidation has the same shape: expression and purification do not establish the amide until the processed product is compared with the acid-form hypothesis (Zhang and colleagues, 2004).

The record that closes the assignment is readable without reopening the raw software. It carries the sequence with an explicit C-terminal symbol, both theoretical monoisotopic masses, the observed mass, ion type, and the error against the rejected formula. It identifies the fragment evidence and, if used, the survival-yield reference pair, charge state and energy scale. It states the reporting threshold for residual acid or ester. Lot identifier, method identifier, analysis date and reviewer sign-off tie the spectrum to the batch in an Australian research-laboratory file. The phrasing C-terminal amide assigned; residual acid below the stated threshold; site localised by the attached fragments is a result. The phrasing meets specification, with no numbers and no rejected acid-form mass, is only a label.

Frequently asked questions

What mass difference separates a C-terminal acid from a C-terminal amide?

The monoisotopic masses differ by 0.984 Da, because the terminal hydroxyl of the carboxylic acid is replaced by an amino group in the primary amide. On a nominal scale that is a one-dalton gap. The same gap is produced by a single deamidation elsewhere in the chain, so the number assigns a composition only after ion type and alternative formulae are written down. It does not, by itself, locate the amide at the C-terminus.

Can nominal-mass spectrometry confirm C-terminal amidation?

Nominal-mass data can suggest which integer formula is closer, but a calibration offset of about one dalton can exchange the acid and amide assignments. Isotope-peak labelling errors move the reported value in the same direction. Confirmation at research-record standard needs a high-resolution mass error against both formulae, or an orthogonal result such as survival yield or site-specific fragments. A unit-mass match to the intended amide, printed alone, is not that confirmation.

Why does methionine complicate amide-site assignment?

Methionine-associated α-amidation has been reported at both the N-terminal and the C-terminal amino acids, so an amide composition can arise at either end. The two isomers share an intact mass. Fragment series have to be inspected: a C-terminal amide shifts C-terminal fragment ions, whereas an N-terminal amide shifts N-terminal fragment ions. If methionine is present and the termini are not covered, the site assignment should remain open on the record.

Is survival yield a purity result?

No. Survival yield is the fraction of precursor remaining after collisional activation. It can reveal C-terminal amidation when the same sequence is compared as acid and as amide, as shown with the survival-yield technique. It is not an area-percent purity, and it does not locate the amide if several sites are possible. The charge state, activation scale and reference pair have to travel with the number or the comparison cannot be re-read.

What should a research record show before a C-terminal amide is assigned?

The sequence should show an explicit amide or acid symbol at the C-terminus, with theoretical masses for both forms, the observed mass, the ion type and the error against the rejected formula. Site evidence and any survival-yield reference pair should be identified. Residual acid or ester should be reported against a stated threshold. Lot, method, date and reviewer sign-off should tie that package to the batch. A purity percentage alone does not assign the terminus.

References

1. DOI:10.1002/(sici)1521-3773(19980803)37:13/14 — C-Terminal Peptide Amidation Catalyzed by Orange Flavedo Peptide Amidase — Angewandte Chemie International Edition — 1998
2. DOI:10.1042/ba20000082 — Studies on peptide amidase-catalysed C-terminal peptide amidation in organic media with respect to its substrate specificity — Biotechnology and Applied Biochemistry — 2001
3. DOI:10.1016/s1046-5928(04)00112-3 — Expression, purification, and C-terminal amidation of recombinant human glucagon-like peptide-1 — Protein Expression and Purification — 2004
4. DOI:10.1002/psc.3429 — Methionine‐associated peptide α‐amidation is directed both to the N‐ and the C‐terminal amino acids — Journal of Peptide Science — 2022
5. DOI:10.1016/j.ab.2022.114823 — Revealing C-terminal peptide amidation by the use of the survival yield technique — Analytical Biochemistry — 2022
6. DOI:10.1021/jacsau.3c00792 — Computational Enzyme Redesign Enhances Tolerance to Denaturants for Peptide C-Terminal Amidation — JACS Au — 2024

Research use only

This article is provided for laboratory research and educational purposes only. Products referenced are not for human or veterinary use. ClaraScience makes no therapeutic, medical, or efficacy claims, and nothing here constitutes medical advice.